Details for 2021207246

Up to date per 01.04.2026

Actions

Title / Product Name

VERWENDUNG VON RILUZOL, RILUZOLPRODRUGS ODER RILUZOLANALOGA MIT IMMUNTHERAPIEN ZUR BEHANDLUNG VON KREBS

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2021207246

EP Publication Number

4019019

E-Number

1654937

Language

PCT Number

Publication Date

29.06.2022 A

07.02.2024 B1

Registration Date

07.02.2024

AT Publication Date

15.02.2024

Application Date

19.05.2017

Registration Number

Priorities

20.05.2016

201662339433 P

IPC

A61K 31/428 20060101AFI20220429BHEP

Maximum Duration of Protection

19.05.2037

Owner

Biohaven Therapeutics Ltd.215 Church Street New Haven, CT 06510US

Representative

Patentanwalt Mikšovsky KGBisamberger Straße 192100 KorneuburgAT

Inventor

CORIC, Vladimir New Haven, 06520US

Information about Fees